Table 1 –
Clinical characteristics | Cluster I early disrupted homeostasis (N = 18) | Cluster II early preserved homeostasis (N = 139) | P value |
---|---|---|---|
| |||
Demographics | |||
Age, median (25th, 75th) | 64 (56, 69) | 62 (50, 70) | 0.35 |
Male gender, n (%) | 11 (61) | 74 (53) | 0.62 |
Race, n (%) | |||
White | 15 (83) | 124 (89) | 0.07 |
African American | 1 (6) | 12 (9) | |
American Indian | 0 (0) | 1 (0.7) | |
Transferred from another hospital, n (%) | 8 (44) | 64 (46) | 1.00 |
Weight (kg), median (25th, 75th) | 98 (64, 136) | 86 (71, 103) | 0.28 |
Body Mass index, median (25th, 75th) | 35 (21, 45) | 29 (25, 34) | 0.36 |
Comorbidities, n (%) | |||
Chronic kidney disease* | 7 (47) | 15 (11) | 0.001 |
Congestive heart failure | 7 (39) | 20 (14) | 0.02 |
Chronic obstructive pulmonary disease† | 2 (12) | 17 (12) | 1.00 |
Diabetes mellitus† | 8 (47) | 45 (33) | 0.28 |
Hypertension | 13 (76) | 81 (59) | 0.20 |
Smoking history, n (%) | |||
Current | 4 (24) | 57 (42) | 0.21 |
Former | 1 (6) | 15 (11) | |
Never | 12 (71) | 64 (47) | |
Characteristics of sepsis episode | |||
Sepsis severity, n (%) | |||
Sepsis | 0 (0) | 57 (41) | < 0.001 |
Severe sepsis | 4 (22) | 58 (42) | |
Septic shock | 14 (78) | 24 (17) | |
Acuity scores in the first 24 h of sepsis onset, median (25th, 75th) | |||
APACHE II | 30 (26, 39) | 16 (11, 21) | < 0.001 |
Total acute physiology score | 23 (20, 34) | 12 (8, 17) | < 0.001 |
Age points | 4 (3, 5) | 3 (2, 5) | 0.19 |
Chronic health points | 0 (0, 2) | 0 (0, 0) | 0.001 |
SOFA | 13 (11, 15) | 5 (2, 8) | < 0.001 |
Respiratory system | 3 (2, 3) | 0 (0, 3) | < 0.001 |
Central nervous system | 3 (2, 4) | 1 (0, 2) | 0.002 |
Cardiovascular system | 3 (3, 4) | 1 (0, 1) | < 0.001 |
Liver | 1 (0, 2) | 0 (0, 0) | < 0.001 |
Coagulation | 0.5 (0, 2) | 0 (0, 0) | 0.002 |
Renal | 3 (2, 4) | 0 (0, 1) | < 0.001 |
Abbreviations: APACHE II = Acute Physiology and Chronic Health Evaluation II score; SOFA = Sequential Organ Failure Assessment.
Pairs that are significant with P values at 0.05 level are boldfaced.
Percentages calculated after removing end-stage renal disease (ESRD) patients from the cohort.
Due to missing values, the percentages were calculated based on the available data.